Related Experiment Videos
The changing approach to the treatment of early breast cancer
The New England Journal of Medicine
|May 23, 1996
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Tailoring treatment to cancer risk and patient preference: the 2025 St Gallen International Breast Cancer Consensus Statement on individualizing therapy for patients with early breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2025
Multiplexed high-throughput immune cell imaging in patients with high-risk triple negative early breast cancer: Analysis from the International Breast Cancer Study Group (IBCSG) Trial 22-00.
European journal of cancer (Oxford, England : 1990)·2024
Understanding breast cancer complexity to improve patient outcomes: The St Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023.
Annals of oncology : official journal of the European Society for Medical Oncology·2023
Genomic characterisation of hormone receptor-positive breast cancer arising in very young women.
Annals of oncology : official journal of the European Society for Medical Oncology·2023
Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021.
Annals of oncology : official journal of the European Society for Medical Oncology·2021
Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019.
Annals of oncology : official journal of the European Society for Medical Oncology·2019
Adult Attention Deficit-Hyperactivity Disorder.
The New England journal of medicine·2026
Long-Acting HIV Therapy in African Adults with Adherence Challenges.
The New England journal of medicine·2026
Phase 2 Trial of Icotrokinra for Patients with Ulcerative Colitis.
The New England journal of medicine·2026
Ponatinib-Blinatumomab or Imatinib-Chemotherapy for Adult Ph-Positive ALL.
The New England journal of medicine·2026
Intermittent or Continuous Renal-Replacement Therapy in Acute Kidney Injury.
The New England journal of medicine·2026